Score Overview
Capricor Therapeutics Inc fundamental performance
Between 2020 and 2025, revenue declined from $ 310.25K to $ 0.00 and net income went from -$ 13M to -$ 105M. Revenue increased in 2 of those 5 years; net income in 1.
Across Capricor Therapeutics Inc's full reported history, from 2007 to 2025, revenue declined from $ 101.4K to $ 0.00 and net income went from -$ 10M to -$ 105M. Revenue increased in 33% of the years measured; net income in 42%.
Capricor Therapeutics Inc currently holds a 5-year HDB Score of 1.7 out of 10. How the HDB Score is calculated.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 4.19 | — |
1 Year2025-08-12 | $ 8.04 | -47.89% |
5 Years2021-08-12 | $ 4.48 | -6.47% |
10 Years2016-08-12 | $ 35.20 | -88.10% |
20 Years2006-07-21 | $ 3.50 | 19.71% |
All Time2007-02-13 | $ 450.00 | -99.07% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | 10 Years2016-08-12 | 20 Years2006-07-21 | All Time2007-02-13 |
|---|---|---|---|---|---|---|
| Price | $ 4.19 | $ 8.04 | $ 4.48 | $ 35.20 | $ 3.50 | $ 450.00 |
| Return | — | -47.89% | -6.47% | -88.10% | 19.71% | -99.07% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 0.00 | -$ 114M | $ 278M |
| 2025 | $ 0.00 | -$ 105M | $ 318M |
| 2024 | $ 22M | -$ 40M | $ 151M |
| 2023 | $ 25M | -$ 22M | $ 39M |
| 2022 | $ 2M | -$ 29M | $ 41M |
| 2021 | $ 244.9K | -$ 20M | $ 34M |
| 2020 | $ 310.25K | -$ 13M | $ 32M |
| 2019 | $ 1M | -$ 7M | $ 9M |
| 2018 | $ 1M | -$ 15M | $ 7M |
| 2017 | $ 1M | $ 2M | $ 14M |
| 2016 | $ 3M | -$ 18M | $ 16M |
| 2015 | $ 3M | -$ 12M | $ 13M |
| 2014 | $ 4M | -$ 6M | $ 8M |
| 2013 | $ 503.23K | -$ 8M | $ 2M |
| 2012 | $ 195.5K | -$ 1M | $ 4M |
| 2011 | $ 1M | -$ 4M | $ 1M |
| 2010 | -$ 6M | $ 3M | |
| 2009 | -$ 7M | $ 3M | |
| 2008 | -$ 13M | $ 5M | |
| IPO2007 | $ 101.4K | -$ 10M | $ 16M |
Explore beyond CAPR
You're looking at Capricor Therapeutics Inc. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
